Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00616317

Acronym

APS

Enrollment

Registered

2008-02-15

Start date

2006-09-30

Completion date

2040-01-31

Last updated

2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antiphospholipid Syndrome

Keywords

Antiphospholipid Syndrome

Brief summary

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Minutes to 18 Years

Healthy volunteers

Inclusion criteria

* 18 years of age or younger at the onset of disease * Presence of Vascular Thrombosis * UC Davis patient * Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma

Exclusion criteria

* Infants born to mothers with APS * Infants with congenital thrombophilia

Design outcomes

Primary

Measure	Time frame
Long term survival	10 year

Countries

United States

Contacts

Primary ContactLavjay Butani

(916) 734-8118

Outcome results